Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNetscientific Share News (NSCI)

Share Price Information for Netscientific (NSCI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 62.50
Bid: 60.00
Ask: 65.00
Change: -0.50 (-0.79%)
Spread: 5.00 (8.333%)
Open: 63.00
High: 63.00
Low: 62.50
Prev. Close: 63.00
NSCI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET MIDDAY: FTSE 100 outperforms as UK housebuilders rally

Mon, 07th Jun 2021 12:09

(Alliance News) - London's FTSE 100 outpaced peers at the start of the week, with a Chinese trade data undershoot hitting the sizeable mining contingent in the index but this being outweighed by a boost for the UK housebuilding sector.

The large-cap index was up 21.64 points, or 0.3%, at 7,090.68 on Monday. The mid-cap FTSE 250 index was up 92.50 points, or 0.2%, at 22,925.23. The AIM All-Share index was flat at 1,257.26.

The Cboe UK 100 index was up 0.3% at 706.51. The Cboe 250 was up 0.4% at 20,672.72, and the Cboe Small Companies flat at 15,177.26.

In mainland Europe, the CAC 40 in Paris and the DAX 30 in Frankfurt were both up 0.1% on Monday.

"The tailwind from the weaker-than-expected non-farm payroll report has faded, and sentiment has taken a turn for the worse following downbeat Chinese trade data. Miners are trading down around 1%, tracing base metal prices lower after Chinese export data sparked concern," said Sophie Griffiths, market analyst at Oanda.

China's exports rose 28% in May while imports grew at the fastest pace in more than a decade as the global economy powers back from the pandemic crisis, official data showed overnight. While growth was strong, it failed to live up to expectations of a 32% gain.

Import growth hit its highest rate since January 2011, coming in at 51% on-year, also slightly below expectations of a Bloomberg poll of analysts.

London-listed miners fell in response to the trade data, as China is a major consumer of commodities. Anglo American, which completed demerger of its thermal coal business in South Africa on Monday, was the worst performer in the FTSE 100, down 2.8%. Antofagasta fell 2.1% and Glencore pulled back 1.1%.

More than offsetting the mining sector slide, housebuilders rallied, after Halifax reported that UK house prices hit a fresh record last month.

Persimmon was up 2.8% at midday, Taylor Wimpey up 2.6% and Barratt Developments up 2.4%.

Home prices jumped 9.5% in May on an annual basis, and notched up a monthly gain of 1.3%. The average UK property price now stands at GBP261,743, a new record high, Halifax said. Annual house price inflation is at its strongest level in nearly seven years.

"Heading into the traditionally busy summer period, market activity continues to be boosted by the government's stamp duty holiday, with prospective buyers racing to complete purchases in time to benefit from the maximum tax break ahead of June's deadline, after which there will be a phased return to full rates," said Russell Galley, managing director at Halifax.

Mid-cap housebuilders also advanced, with Crest Nicholson up 3.8%, Redrow up 2.8% and Bellway up 2.7%.

Wall Street is on course to open slightly lower on Monday, with the Dow Jones seen flat, the S&P 500 called down 0.2% and the Nasdaq Composite down 0.5%.

Pierre Veyret, technical analyst at ActivTrades, said: "Investors are still digesting last week's lower-than-expected jobs report...Market sentiment is also being weighed down by Janet Yellen's recent hawkish comments after she said 'slightly higher rates would be a plus', which clearly increases the prospect of taper talks."

Further, traders are anticipating US inflation data later this week. Due on Thursday, the US consumer price index is expected to show annual growth of 4.7% for May, according to FXStreet, which would mark another uptick after April's 4.2% increase.

The dollar edged higher amid caution at the start of the week.

Sterling was quoted at USD1.4138 on Monday, easing from USD1.4169 at the London equities close on Friday.

The euro traded at USD1.2159, down from USD1.2172 late Friday.

German industrial orders unexpectedly fell for the first time in four months in April. Orders were down 0.2% compared to March, according to federal statistics office Destatis, though analysts surveyed by financial data firm Factset had expected another month of growth.

On an annual basis, however, new orders surged by 79% compared to April 2020, when they dropped to their lowest level on record as economic activity shut down due to the coronavirus pandemic.

The safe-haven yen was stable, with the dollar quoted at JPY109.43 on Monday versus JPY109.44 late Friday in London.

Gold was priced at USD1,884.89 an ounce on Monday, lower than USD1,893.48 on Friday. Brent oil was trading at USD71.46 a barrel, soft on USD71.55 late Friday.

Back on the London Stock Exchange, Legal & General rose 1.7% after Goldman Sachs started the life insurance and pensions firm with a Buy rating.

IWG shares tumbled 14% as it warned 2021 earnings face a hit with occupancy rates lower than expected.

The office space provider said underlying earnings before interest, tax, depreciation and amortisation this year will be "well below" the 2020 level. The improvement in occupancy has been lower than expected because of the prolonged effects of the pandemic, the company said.

IWG made GBP1.23 billion adjusted Ebitda in 2020, down 17% from GBP1.48 million in 2019. Back in April, IWG had said that the first quarter of 2021 was an inflection point and that occupancy would increase throughout the second quarter.

The company offered a silver lining in the trading update on Monday, saying it is seeing unprecedented demand for flexible work products and occupancy is improving in the US. Expectations for a strong recovery in 2022 are "broadly unchanged".

The company's comments came as Health Secretary Matt Hancock said the UK government was "absolutely open" to delaying the June 21 unlocking of England. He also implied that social distancing could continue beyond the final stage of the prime minister's road map.

NetScientific shares soared 47% after its subsidiary inked a contract with FTSE 100-listed AstraZeneca for its serology test.

ProAxsis said it has entered into an exclusive licensing agreement with AstraZeneca which will see ProAxsis take responsibility for completing the validation and global commercialisation of a SARS-CoV-2 serology ELISA developed by an internal research team at AstraZeneca. ELISA refers to an enzyme-linked immunosorbent assay.

In return for providing access to the required intellectual property and technical know-how, AstraZeneca will receive a royalty fee on future global net sales of the assay.

AstraZeneca shares were down 0.6% at midday.

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
15 Apr 2024 11:06

NetScientific investee secures funding to develop product range

(Alliance News) - NetScientific PLC on Monday said its portfolio company ProAxsis Ltd secured GBP1.8 million in investment.

Read more
27 Mar 2024 18:47

TRADING UPDATES: Empire Metals targets key milestones in Australia

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
13 Mar 2024 17:04

NetScientific "significantly" advances strategic goals

(Alliance News) - NetScientific PLC on Wednesday released a portfolio and strategy update.

Read more
23 Jan 2024 18:39

TRADING UPDATES: Esken's Southend Airport faces further allegations

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
1 Dec 2023 11:59

IN BRIEF: NetScientific investee DeepTech Recycling bags GBP1 million

NetScientific PLC - technology and life sciences investor - Portfolio company DeepTech Recycling Ltd closes GBP1 million fundraising. DeepTech, in which NetScientific holds a 30% stake, is a company focused on chemical recycling of plastic waste. Last December, it bought the assets of Recycling Technologies Ltd out of administration. The fundraise is carried out via an advance share subscription agreement and is the first closing of a target investment programme of around GBP3 million, with further investment anticipated within the next six months.

Read more
9 Nov 2023 19:41

IN BRIEF: NetScientific's portfolio company updates on cancer trial

NetScientific PLC - London-based deep tech and life sciences-focused venture capital investor -

Read more
6 Nov 2023 12:00

IN BRIEF: NetScientific says Ventive on fire with new investment

NetScientific PLC - London-based deep tech and life sciences-focused venture capital investor - Says portfolio company Ventive, a London-based designer and manufacturer of heating and ventillation solutions, has successfuly closed a new investment of around GBP900,000. Funding included GBP316,000 from existing shareholders and the conversion of two existing convertible loans valued at about GBP600,000. Investment is part of Ventive's proposed GBP1 million to GBP1.5 million programme, with further investments expected by April 30. NetScientific now holds an 11% total equity stake in Ventive, with a post-investment fair value of GBP893,000 - up from GBP52,000 at December 31.

Read more
23 Oct 2023 21:10

NetScientific investee claims promising results in biomarker study

(Alliance News) - NetScientific PLC on Monday said its investee PDS Biotechnology Corp was "encouraged" by study data for its PDS0101 combined with Merck & Co Inc's drug Keytruda.

Read more
3 Oct 2023 17:12

IN BRIEF: NetScientific portfolio company updates on cancer trial

NetScientific PLC - London-based deep tech and life sciences-focused venture capital investment company - Reports that its portfolio company, PDS Biotechnology Corp, has announced updated interim data from the Versatile-002 phase two clinical trial evaluating PDS0101 in combination with Merck & Co Inc's Keytruda in patients with unresectable, recurrent, or metastatic HPV16-positive head and neck squamous cell carcinoma.

Read more
28 Sep 2023 14:24

EARNINGS: Dar Global profit multiplies, Hemogenyx loss widens

(Alliance News) - The following is a round-up of earnings updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
13 Sep 2023 21:32

NetScientific's Q-Bot completes GBP3.5 million investment programme

(Alliance News) - NetScientific PLC on Wednesday said that its portfolio company, Q-Bot, has successfully closed a GBP3.5 million investment programme.

Read more
14 Aug 2023 19:49

IN BRIEF: NetScientific's PDS suffers wider loss as R&D costs mount

NetScientific PLC - London-based investment firm focused on life science, sustainability and technology companies - Portfolio company PDS Biotechnology Corp reports results for the quarter to June 30. Net loss was USD11.5 million, widened from USD5.8 million the year before. Higher loss primarily due to costs incurred in connection with research and development programmes, which more than doubled to USD8.0 million from USD3.8 million. Loss per share of USD0.37 compared to USD0.20 before. Further, PDS reports the successful submission of final clinical protocol and supporting information to the US Food & Drug Administration to initiate phase 3 Versatile-003 trial in the fourth quarter. Adds biomarker data from Versatile-002 will be presented at the European Society for Medical Oncology Congress.

Read more
30 Jun 2023 14:07

TRADING UPDATES: Pendragon quarterly trading momentum maintained

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
29 Jun 2023 14:11

TRADING UPDATES: tinyBuild bemoans disappointing interim performance

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
22 Jun 2023 17:15

IN BRIEF: NetScientific investee Vortex nabs six-figure investment

NetScientific PLC - London-based investment firm focused on life science, sustainability and technology companies - Announces completion of new GBP3.2 million investment round in portfolio company Vortex Biotech Holdings Ltd, led by EMV Capital. NetScientific converted its GBP400,000 loan into equity alongside new Vortex investors. NetScientific now has a 24.98% total equity holding in Vortex. This equates to a post-investment fair value of GBP2.8 million, quadruple the GBP700,000 value reported at December 31.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.